What's Hot
View all perspectives
Dr. John Cush RheumNow
1 year ago
The Fallacy of Biologic Treatment to Prevent RA
It is time to stop fooling ourselves that we can prevent RA with our existing biologic agents. #ACR23
https://t.co/qHMW4HGkk2 https://t.co/l2Tn7hGtY3
Dr. John Cush RheumNow
1 year ago
RHEUM Survey Question: Your choice of a biologic in patients with SpA is mostly influenced by? CLICK here to answer: https://t.co/tc6S3fysL3
TheDaoIndex KDAO2011
1 year ago
ICYMI - Nice blog! Choice Overload (and the Way Out) https://t.co/dBfgUadEd2 @rheumnow
sheila
1 year ago
Summary of diet effects in RA and SLE patients 👇
Dr. Sarah Patterson also shared nutrition resources for pts and clinicians
https://t.co/ae6nLrLXca
#ACR23 @Rheumnow @rheumarhyme @GerRheumDoc @doktora_ging https://t.co/8HhCHCTGLh
Meral K. El Ramahi, MD MeralElRamahiMD
1 year ago
TM13 @ #ACR23
64 yo F w/ CHF p/w dyspnea, palpitat, chest tight
EKG: monomorph VT
- Prior EKG: intervent conduct delay, LAD
TTE: ant wall abn, EF 35-40%
LHC: LV aneurysm, nonobst CAD
cMRI: abn LV wall thickening
PET: hypermetab LV
Endomyo Bx: necrot granuloma
DX?
@RheumNow
Robert B Chao, MD
1 year ago
Gender differences in switching biologics in PsA pts
Women had higher biologic switch rates, mainly due to lack of efficacy
Other gender specific factors include gestational reasons and different sociodemographic features
@RheumNow #ACR23 Abs#2247 https://t.co/mLm183fCBw
TheDaoIndex KDAO2011
1 year ago
I got a chance to interview first author Jun Chu @nihrheumatology for her study on GnRHa Reducing Premature Ovarian Insufficiency in SLE pts on CYP. Watch here @RheumNow #ACR23 https://t.co/VCvAiRs4ni
Dr. Rachel Tate
1 year ago
Be a SpA (and PsA) Sleuth! My article is your call to arms for better understanding and discovery of IBD in our inflammatory back pain patients. Consider fecal calprotectin AND robust ROS as your magnifying glass! #ACR23 @rheumnow https://t.co/OnQDEWgIWM
Meral K. El Ramahi, MD MeralElRamahiMD
1 year ago
Dx: Necrotizing Sarcoid Granulomatosis (NSG)
➡️rare dz entitiy
➡️common features: cough, F, dyspnea, CP, or wt loss
➡️Bx can be necrot or non-necrot granulmoas
➡️Ddx: TB, GPA
#ACR23 @RheumNow https://t.co/zBGVriB8ka
David Liew drdavidliew
1 year ago
If we're to summarize the challenges to making for CAR-T therapy work in a given disease, this is it:
Dr. Chyi-Song Hsieh @WUSTL #ACR23 @RheumNow https://t.co/raoHtrJ25S
Dr. Rachel Tate
1 year ago
From patient to research/clinical rheumatologist and SpA advocate. Check out my #ACR23 interview with Dr. Hillary Norton. @DrHillaryNorton @RheumNow https://t.co/SeZeqb8wid
Dr. Rachel Tate
1 year ago
Dr. Alexis Ogdie updates me on her #ACR23 must knows for SpA/PsA patients @RheumNow https://t.co/hFLzLtmcSl
Meral K. El Ramahi, MD MeralElRamahiMD
1 year ago
TM06 @ #ACR23: A Force Awakens
86 yo retired attorney w/ HTN, HLD p/w F, chills
4 mo ago:
- mild MDS on BMBx, cytogen neg
- new rash + Cr rise to 3 mg/dl, resolved w/ pred
3 mo ago: wt loss
1 mo ago: chondritis (ear, nose)
1 wk ago: b/l eye red + pain
DIAGNOSIS?
@RheumNow https://t.co/PdtAxnkXaJ
Eric Dein
1 year ago
Great summary of the big takeaways yesterday at #ACR23. Always love talking to @KDAO2011 @EBRheum @RheumNow
We get into the use of MTX, the safety on TNFs and what is in the purview of rheumatology practice https://t.co/jm0a8ndrsi
Dr. Antoni Chan
1 year ago
Editorial position on the use of AI in publishing. AI cannot be listed as an author ✍️ Smolen J, #ACR23 @RheumNow https://t.co/P2eOmi6W5c
Poster Hall